Market closed
VolitionRX/VNRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About VolitionRX
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Ticker
VNRX
Sector
Trading on
AMEX
Industry
Health Care Equipment & Supplies
Headquarters
Employees
101
Website
VolitionRX Metrics
BasicAdvanced
$65M
Market cap
-
P/E ratio
-$0.40
EPS
1.14
Beta
-
Dividend rate
Price and volume
Market cap
$65M
Beta
1.14
52-week high
$1.23
52-week low
$0.43
Average daily volume
105K
Financial strength
Current ratio
0.237
Quick ratio
0.199
Long term debt to equity
-20.002
Total debt to equity
-25.597
Interest coverage (TTM)
-121.19%
Management effectiveness
Return on assets (TTM)
-100.82%
Return on equity (TTM)
368.80%
Valuation
Price to revenue (TTM)
58.554
Price to book
-2.7
Price to tangible book (TTM)
-2.66
Price to free cash flow (TTM)
-3.2
Growth
Revenue change (TTM)
88.32%
Earnings per share change (TTM)
-27.06%
3-year revenue growth (CAGR)
156.29%
3-year earnings per share growth (CAGR)
-1.53%
What the Analysts think about VolitionRX
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for VolitionRX stock.
VolitionRX Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
VolitionRX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for VolitionRX stock?
VolitionRX (VNRX) has a market cap of $65M as of October 24, 2024.
What is the P/E ratio for VolitionRX stock?
The price to earnings (P/E) ratio for VolitionRX (VNRX) stock is 0 as of October 24, 2024.
Does VolitionRX stock pay dividends?
No, VolitionRX (VNRX) stock does not pay dividends to its shareholders as of October 24, 2024.
When is the next VolitionRX dividend payment date?
VolitionRX (VNRX) stock does not pay dividends to its shareholders.
What is the beta indicator for VolitionRX?
VolitionRX (VNRX) has a beta rating of 1.14. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.